PDE5 — Drug Target

All drugs that target PDE5 — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Phosphodiesterase type 5 inhibitor · PDE5 inhibitor · Phosphodiesterase 5 inhibitor

Phase 3 pipeline (3)

• Sublingual sildenafil · N4 Pharma UK Ltd. · Phosphodiesterase type 5 inhibitor · Urology
  Sublingual sildenafil works by increasing blood flow to the penis to treat erectile dysfunction.
• placebo (tadalafil) · Eli Lilly and Company · PDE5 inhibitor · Urology
  Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor, which works by increasing blood flow to the penis to treat erectile dysfunction.
• iv sildenafil · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · PDE5 inhibitor · Urology
  Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor that works by increasing blood flow to the penis to treat erectile dysfunction.

Phase 2 pipeline (1)

• Aristo Sildaristo · Aspargo Labs, Inc · Phosphodiesterase 5 inhibitor · Urology
  Aristo Sildaristo is a phosphodiesterase 5 inhibitor.